Publications
Found 7 results
Filters: Author is H. Yao [Clear All Filters]
“Effect of uric acid on mitochondrial function and oxidative stress in hepatocytes”, vol. 15, p. -, 2016.
, “Effect of uric acid on mitochondrial function and oxidative stress in hepatocytes”, vol. 15, p. -, 2016.
, “Applying DNA barcodes for identification of economically important species in Brassicaceae”, vol. 14, pp. 15050-15061, 2015.
, “Role of inflammatory responses in the pathogenesis of human cerebral aneurysm”, vol. 14, pp. 9062-9070, 2015.
, “DNA barcoding of populations of Fallopia multiflora, an indigenous herb in China”, vol. 12, pp. 4078-4089, 2013.
, “MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3”, vol. 12, pp. 1012-1021, 2013.
, Ambros V and Chen X (2007). The regulation of genes and genomes by small RNAs. Development 134: 1635-1641.
http://dx.doi.org/10.1242/dev.002006
PMid:17409118
Berezikov E, Guryev V, van de Belt J, Wienholds E, et al. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
http://dx.doi.org/10.1016/j.cell.2004.12.031
PMid:15652478
Chen C, Ridzon DA, Broomer AJ, Zhou Z, et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33: e179.
http://dx.doi.org/10.1093/nar/gni178
PMid:16314309 PMCid:1292995
Chen H, Chen Q, Fang M and Mi Y (2009). Regulatory effect on the proliferation of the leukemic cell HL-60 by miRNA- 181b through MLK2 science in China. Life Sci. 39: 1034-1040.
de Yébenes VG, Belver L, Pisano DG, Gonzalez S, et al. (2008). miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206.
http://dx.doi.org/10.1084/jem.20080579
PMid:18762567 PMCid:2556787
Debernardi S, Skoulakis S, Molloy G, Chaplin T, et al. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916.
PMid:17330104
Gibson W, Green A, Bullard RS, Eaddy AC, et al. (2007). Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Lett. 248: 251-261.
http://dx.doi.org/10.1016/j.canlet.2006.08.007
PMid:16996682
Jonler M and Pedersen KV (2007). Diagnosis, evaluation and follow-up of patients with prostatic cancer. Ugeskr. Laeger 169: 1889-1891.
PMid:17553363
Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
http://dx.doi.org/10.1006/meth.2001.1262
PMid:11846609
Marcucci G, Radmacher MD, Maharry K, Mrózek K, et al. (2008). MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358: 1919-1928.
http://dx.doi.org/10.1056/NEJMoa074256
PMid:18450603
Meltzer PS (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
http://dx.doi.org/10.1038/435745a
PMid:15944682
Nakajima G, Hayashi K, Xi Y, Kudo K, et al. (2006). Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324.
PMid:18172508 PMCid:2170889
Ozen M, Creighton CJ, Ozdemir M and Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793.
http://dx.doi.org/10.1038/sj.onc.1210809
PMid:17891175
Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66: 11590-11593.
http://dx.doi.org/10.1158/0008-5472.CAN-06-3613
PMid:17178851
Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, et al. (2007). MicroRNA expression profiling in prostate cancer. Cancer Res. 67: 6130-6135.
http://dx.doi.org/10.1158/0008-5472.CAN-07-0533
PMid:17616669
Prueitt RL, Yi M, Hudson RS, Wallace TA, et al. (2008). Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164.
http://dx.doi.org/10.1002/pros.20786
PMid:18459106 PMCid:2597330
Rajewsky N (2006). microRNA target predictions in animals. Nat. Genet. 38 Suppl: S8-13.
http://dx.doi.org/10.1038/ng1798
PMid:16736023
Schaefer A, Jung M, Mollenkopf HJ, Wagner I, et al. (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126: 1166-1176.
PMid:19676045
Shi L, Cheng Z, Zhang J, Li R, et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236: 185-193.
http://dx.doi.org/10.1016/j.brainres.2008.07.085
PMid:18710654
Spahn M, Kneitz S, Scholz CJ, Stenger N, et al. (2010). Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int. J. Cancer 127: 394-403.
PMid:19585579
Stark A, Brennecke J, Bushati N, Russell RB, et al. (2005). Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146.
http://dx.doi.org/10.1016/j.cell.2005.11.023
PMid:16337999
Volinia S, Calin GA, Liu CG, Ambs S, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
http://dx.doi.org/10.1073/pnas.0510565103
PMid:16461460 PMCid:1413718
Xu L and Wang GM (2007). The progress and current situation in the management of moderate and far advanced prostate cancer. Int. J. Urol. Nephrol. 27: 773.
Zhang B and Farwell MA (2008). microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J. Cell Mol. Med. 12: 3-21.
http://dx.doi.org/10.1111/j.1582-4934.2007.00196.x
PMid:18088390
“Genetic linkage analysis of oral lichen planus in a Chinese family”, vol. 10, pp. 1427-1433, 2011.
, Axéll T and Rundquist L (1987). Oral lichen planus - a demographic study. Community Dent. Oral Epidemiol. 15: 52-56.
doi:10.1111/j.1600-0528.1987.tb00480.x
PMid:3467894
Bai J, Jiang L, Lin M, Zeng X, et al. (2009). Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J. Interferon Cytokine Res. 29: 381-388.
doi:10.1089/jir.2008.0089
Bermejo-Fenoll A and Lopez-Jornet P (2006). Familial oral lichen planus: presentation of six families. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102: e12-e15.
doi:10.1016/j.tripleo.2006.03.016
PMid:16876038
Camisa C and Popovsky JL (2000). Effective treatment of oral erosive lichen planus with thalidomide. Arch. Dermatol. 136: 1442-1443.
doi:10.1001/archderm.136.12.1442
PMid:11115153
Chaiyarit P, Kafrawy AH, Miles DA, Zunt SL, et al. (1999). Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis. J. Oral Pathol. Med. 28: 210-215.
doi:10.1111/j.1600-0714.1999.tb02026.x
Dan H, Liu W, Zhou Y, Wang J, et al. (2010). Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 33: 76-81.
doi:10.1007/s10753-009-9160-0
PMid:19842025
Fujita H, Kobayashi T, Tai H, Nagata M, et al. (2009). Assessment of 14 functional gene polymorphisms in Japanese patients with oral lichen planus: a pilot case-control study. Int. J. Oral Maxillofac. Surg. 38: 978-983.
doi:10.1016/j.ijom.2009.05.001
PMid:19497711
Jungell P (1991). Oral lichen planus. A review. Int. J. Oral Maxillofac. Surg. 20: 129-135.
doi:10.1016/S0901-5027(05)80001-3
Liu W, Dan H, Wang Z, Jiang L, et al. (2009). IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 32: 176-181.
doi:10.1007/s10753-009-9118-2
PMid:19370405
Lozada-Nur F and Miranda C (1997). Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin. Cutan. Med. Surg. 16: 273-277.
doi:10.1016/S1085-5629(97)80016-8
Petropoulou H, Kontochristopoulos G, Kalogirou O, Panteri I, et al. (2006). Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus. Int. J. Dermatol. 45: 1244-1245.
doi:10.1111/j.1365-4632.2006.02949.x
PMid:17040454
Scardina GA, Ruggieri A, Messina P and Maresi E (2009). Angiogenesis of oral lichen planus: a possible pathogenetic mechanism. Med. Oral Patol. Oral Cir. Bucal. 14: e558-e562.
doi:10.4317/medoral.14.e558
Silverman S Jr and Bahl S (1997). Oral lichen planus update: clinical characteristics, treatment responses, and malignant transformation. Am. J. Dent. 10: 259-263.
PMid:9590911
Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, et al. (2004). Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J. Oral Pathol. Med. 33: 386-390.
doi:10.1111/j.1600-0714.2004.00221.x
PMid:15250829
Sugerman PB, Satterwhite K and Bigby M (2000). Autocytotoxic T-cell clones in lichen planus. Br. J. Dermatol. 142: 449-456.
doi:10.1046/j.1365-2133.2000.03355.x
PMid:10735949
Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, et al. (2002). The pathogenesis of oral lichen planus. Crit. Rev. Oral Biol. Med. 13: 350-365.
doi:10.1177/154411130201300405
van der Meij EH, Mast H and van der Waal I (2007). The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 43: 742-748.
doi:10.1016/j.oraloncology.2006.09.006
PMid:17112770
Vincent SD, Fotos PG, Baker KA and Williams TP (1990). Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg. Oral Med. Oral Pathol. 70: 165-171.
doi:10.1016/0030-4220(90)90112-6
Wilson E (1869). On lichen planus. J. Cutan. Med. Dis. Skin. 3: 117-132.